Corey Rosen
Symbria ESOP Valuation Lawsuit Can Continue, but Non-Trustee Defendants Dropped from Case
In Placht v. Argent et. al., No. 1:21-cv-05783 D (N.D. Ill., August 10, 2022), a district court allowed plaintiffs to proceed in an ESOP valuation case against the trustee, Argent Trust, but not the 12 other named defendants, who are all sellers in the transaction. Symbria provides rehabilitation services, wellness programs, pharmacy services, experience surveys, and strategic consulting services to senior-living and post-acute providers. The 2015 deal was for $66.5 million and was funded entirely with debt. Post-transaction, the value dropped to $9.3 million, and was valued at $8.65 million in 2020. Plaintiffs allege the ESOP overpaid for the shares. The court dropped 12 selling shareholders from the suit because they were not fiduciaries, but allowed claims against certain managers to continue.
